Cyclooxygenase-2 Overexpression is Associated with Clinical Outcome in Biliary Atresia

Abstract

Objective: The purpose of this study was to investigate the association between cyclooxygenase-2 (COX-2) expression and clinical outcome in biliary atresia (BA) patients.

Methods: Six months after surgery, twenty-eight BA patients were divided into three groups according to their liver function tests: group A with satisfactory liver function (n=11), group B with moderate liver dysfunction (n=8), and group C with severe liver dysfunction (n=9). COX-2 expression was determined by immunohistochemistry. Choledochal cysts (n=5) and normal liver samples (n=4) served as controls.

Results: Our data have shown that the intrahepatic biliary epithelium in BA specimens expressed COX-2. The mean immunoreactive score of COX-2 in BA patients was significantly higher than that in choledochal cyst and normal liver (4.0±0.6, 0.9±0.3, and 0.7±0.3, respectively, p<0.002). Strong expression of COX-2 was observed in BA patients with severe liver dysfunction. Subgroup analysis showed that the mean COX-2 immunoreactive scores of patients in group A, B, and C were 2.1±0.6, 3.6±1.1, and 5.9±0.9, respectively. The COX-2 immunoreactive score in BA patients with severe liver dysfunction was higher than in patients with satisfactory liver function (p<0.005).

Conclusion: Increased COX-2 expression of biliary epithelial cells at the time of Kasai operation was associated with an adverse therapeutic outcome in BA, suggesting that COX-2 could play a plausible role in the liver pathology of BA.

Key words

biliary atresia - clinical outcome - cyclooxygenase-2 - jaundice

References

• 1 A-Kader HH, Abdel-Hameed A, Al-Shabrawi M. et al . Is biliary atresia an autoimmune disease?.  Eur J Gastroenterol Hepatol. 2003;  15 447
• 2 Balistreri WF, Grand R, Hoofnagle JH. et al . Biliary atresia: current concepts and research directions.  Hepatology. 1996;  23 1682-1692
• 3 Chayanupatkul M, Honsawek S, Vejchapipat P. et al . Elevated serum bone morphogenetic protein 7 levels and clinical outcome in children with biliary atresia.  Eur J Pediatr Surg. 2009;  19 246-250
• 4 Cheng AS, Chan HL, Leung NW. et al . Expression of cyclooxygenase-2 in chronic hepatitis B and the effects of anti-viral therapy.  Aliment Pharmacol Ther. 2002;  16 251-260
• 5 Cheng J, Imanishi H, Iijima H. et al . Expression of cyclooxygenase 2 and cytosolic phospholipase A(2) in the liver tissue of patients with chronic hepatitis and liver cirrhosis.  Hepatol Res. 2002;  23 185-195
• 6 Davenport M. Biliary atresia.  Semin Pediatr Surg. 2005;  14 42-48
• 7 Davenport M, Gonde C, Redkar R. et al . Immunohistochemistry of the liver and biliary tree in extrahepatic biliary atresia.  J Pediatr Surg. 2001;  36 1017-1025
• 8 DuBois RN, Abramson SB, Cofford L. et al . Cyclooxygenase in biology and disease.  FASEB J. 1998;  12 1063-1073
• 9 El-Bassiouny AE, Zoheiry MM, Nosseir MM. et al . Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.  Med Gen Med. 2007;  9 45
• 10 Hla T, Bishop-Bailey D, Liu CH. et al . Cyclooxygenase-1 and -2 isoenzymes.  Int J Biochem Cell Biol. 1999;  31 551-557
• 11 Honsawek S, Chongsrisawat V, Vejchapipat P. et al . Elevation of serum stem-cell factor in postoperative biliary atresia.  Pediatr Int. 2007;  49 888-893
• 12 Honsawek S, Chongsrisawat V, Vejchapipat P. et al . Serum interleukin-8 in children with biliary atresia: relationship with disease stage and biochemical parameters.  Pediatr Surg Int. 2005;  21 73-77
• 13 Hui AY, Leung WK, Chan HL. et al . Effect of celecoxib on experimental liver fibrosis in rat.  Liver Int. 2006;  26 125-136
• 14 Kim SM, Park KC, Kim HG. et al . Effect of selective cyclooxygenase-2 inhibitor meloxicam on liver fibrosis in rats with ligated common bile ducts.  Hepatol Res. 2008;  38 800-809
• 15 Koga H, Sakisaka S, Ohishi M. et al . Expression of cyclooxygenase-2 in human hepatocellular carcinoma: relevance to tumor dedifferentiation.  Hepatology. 1999;  29 688-696
• 16 Liu C, Chiu JH, Chin T. et al . Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.  J Pediatr Surg. 2000;  35 1591-1596
• 17 Mohammed NA, Abd El-Aleem SA, El-Hafiz HA. et al . Distribution of constitutive (COX-1) and inducible (COX-2) cyclooxygenase in postviral human liver cirrhosis: a possible role for COX-2 in the pathogenesis of liver cirrhosis.  J Clin Pathol. 2004;  57 350-354
• 18 Morinaga S, Yamamoto Y, Noguchi Y. et al . Cyclooxygenase-2 mRNA is up-regulated in cirrhotic or chronic hepatitis liver adjacent to hepatocellular carcinoma.  J Gastroenterol Hepatol. 2002;  17 1110-1116
• 19 Pazirandeh S, Khettry U, Gordon FD. et al . Cyclooxygenase-2 expression in hepatocellular carcinoma, cirrhosis and chronic hepatitis in the United States.  Dig Dis Sci. 2007;  52 220-227
• 20 Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2.  J Biol Chem. 1996;  271 33157-33160
• 21 Vejchapipat P, Theamboonlers A, Poomsawat S. et al . Serum transforming growth factor-beta1 and epidermal growth factor in biliary atresia.  Eur J Pediatr Surg. 2008;  18 415-418
• 22 Vejchapipat P, Poomsawat S, Imvised T. et al . Overexpression of hepatic inducible nitric oxide synthase in biliary atresia.  Hepatol Res. 2008;  38 1018-1025
• 23 Williams CS, DuBois RN. Prostaglandin endoperoxide synthase: Why two isoforms?.  Am J Physiol. 1996;  270 G393-G400
• 24 Yu J, Hui AY, Chu ES. et al . The anti-inflammatory effect of celecoxib does not prevent liver fibrosis in bile duct-ligated rats.  Liver Int. 2009;  29 25-36

Correspondence